Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03368079 · ClinicalTrials.gov registry record · NA

Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia

A NA study of Oropharyngeal Dysphagia, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03368079 is a NA study of Oropharyngeal Dysphagia that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 10 participants, below the 109-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03368079, a NA study of Oropharyngeal Dysphagia, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.

Conditions Studied

Interventions

  • DEVICE Negative Pressure Suction Catheter

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2016-01-30
Est. Completion 2025-12-30
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03368079

The ClinicalTrials.gov registry entry for NCT03368079 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (91% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Oropharyngeal Dysphagia appearing as the primary indexed condition, and to 1 intervention - of which Negative Pressure Suction Catheter is the first listed.

NCT03368079 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03368079 about?

NCT03368079 is a clinical study titled "Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia". This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.

What is the current status of trial NCT03368079?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2016-01-30. Estimated completion is 2025-12-30.

What conditions does trial NCT03368079 study?

This clinical trial studies the following conditions: Oropharyngeal Dysphagia.

What interventions are being tested in trial NCT03368079?

The interventions under investigation include: Negative Pressure Suction Catheter (DEVICE).

Who is sponsoring clinical trial NCT03368079?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03368079 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oropharyngeal Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.